# A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD

> **NCT03994224** · — · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 13 (actual)

## Conditions studied

- Crohn Disease
- Perianal Crohn Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03994224
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-18
- **Primary completion:** 2022-08-29
- **Final completion:** 2022-08-29
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Decision made by team of investigators
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03994224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03994224, "A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03994224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*